External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home 2026 ASCO® Gastrointestinal Cancers Symposium
Roche and Genentech at

2026 ASCO® Gastrointestinal Cancers Symposium

January 08 - January 10
San Francisco, USA / Virtual (Hybrid)
conferences.asco.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:00 PM
Duration 55mins San Francisco, USA
Phase I/Ib study of inavolisib (INAVO) + bevacizumab (BEV) or cetuximab (CETUX) for PIK3CA-mutated (mut) metastatic colorectal cancer (mCRC)
Marwan Fakih, Eric Chen, Keun-Wook Lee, Tanios Bekaii-Saab, Sara Lonardi, Jun Gong, Elena Elez, Janet Lau, Vanessa Breton, Omara Khan, Olga Chertkova, Saket Jain, Sae Won Han
Oncology | Pancreatic Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.